via Pixabay
Researchers say how quickly a person’s pupil dilates while taking cognitive tests
Alzheimer’s disease (AD) begins to alter and damage the brain years — even decades — before symptoms appear, making early identification of AD risk paramount to slowing its progression.
In a new study published online in the September 9, 2019 issue of the Neurobiology of Aging, scientists at University of California San Diego School of Medicine say that, with further developments, measuring how quickly a person’s pupil dilates while they are taking cognitive tests may be a low-cost, low-invasive method to aid in screening individuals at increased genetic risk for AD before cognitive decline begins.
In recent years, researchers investigating the pathology of AD have primarily directed their attention at two causative or contributory factors: the accumulation of protein plaques in the brain called amyloid-beta and tangles of a protein called tau. Both have been linked to damaging and killing neurons, resulting in progressive cognitive dysfunction.
The new study focuses on pupillary responses which are driven by the locus coeruleus (LC), a cluster of neurons in the brainstem involved in regulating arousal and also modulating cognitive function. Tau is the earliest occurring known biomarker for AD; it first appears in the LC; and it is more strongly associated with cognition than amyloid-beta. The study was led by first author William S. Kremen, PhD, and senior author Carol E. Franz, PhD, both professors of psychiatry and co-directors of the Center for Behavior Genetics of Aging at UC San Diego School of Medicine.
The LC drives pupillary response — the changing diameter of the eyes’ pupils — during cognitive tasks. (Pupils get bigger the more difficult the brain task.) In previously published work, the researchers had reported that adults with mild cognitive impairment, often a precursor to AD, displayed greater pupil dilation and cognitive effort than cognitively normal individuals, even if both groups produced equivalent results. Critically, in the latest paper, the scientists link pupillary dilation responses with identified AD risk genes.
“Given the evidence linking pupillary responses, LC and tau and the association between pupillary response and AD polygenic risk scores (an aggregate accounting of factors to determine an individual’s inherited AD risk), these results are proof-of-concept that measuring pupillary response during cognitive tasks could be another screening tool to detect Alzheimer’s before symptom appear,” said Kremen.
Learn more: How the Eyes Might Be Windows to the Risk of Alzheimer’s Disease
The Latest on: Diagnosing Alzheimer’s
via Google News
The Latest on: Diagnosing Alzheimer’s
- Tampa Alzheimer’s Walkon August 1, 2022 at 11:37 am
I walk to find a cure so memories stay alive and so no one has to suffer from one of the cruelest diseases there is.
- New Evidence Confirms Genetic Link Between Gut Health and Alzheimer’son August 1, 2022 at 10:00 am
Those with gastrointestinal disorders may be at greater risk of developing Alzheimer's disease, as there is a genetic link between the two, according to new research from Edith Cowan University.
- ALZHEIMER'S ASSOCIATION LAUNCHES ALZ-NET: A LONG-TERM DATA COLLECTION AND SHARING NETWORK FOR NEW TREATMENTSon August 1, 2022 at 8:17 am
The Alzheimer's Association announces that the Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) — a new platform that will collect long-term clinical and safety data from patients treated ...
- Alzheimer's breakthrough test could spot signs 17 years before symptoms appearon August 1, 2022 at 2:24 am
A test could spot signs of Alzheimer's 17 years before symptoms first appear, according to new research. Scientists hope that the disease will be stopped while patients still show no signs and before ...
- Experts release appropriate use recommendations for Alzheimer’s disease blood biomarkerson July 31, 2022 at 8:14 pm
Alzheimer’s disease blood biomarkers (BBMs) may revolutionize the diagnosis of Alzheimer’s in the future, but are not yet ready for widespread use, according to a newly-published article by leading ...
- Alzheimer's Community Remains Optimistic Despite Reports of Fraud in 2006 Studyon July 31, 2022 at 5:12 pm
An investigative report has concluded that images were falsified in a landmark 2006 Alzheimer's study, but many experts in the field remain optimistic ...
- ALZHEIMER'S ASSOCIATION GLOBAL WORKGROUP RELEASES RECOMMENDATIONS ABOUT USE OF ALZHEIMER'S "BLOOD TESTS"on July 31, 2022 at 8:07 am
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022Top Tier Clinicians and Researchers Find the Tests Are:- Full of Revolutionary ...
- The fight against Alzheimer's: Where are we now?on July 31, 2022 at 12:02 am
Decades of Alzheimer's research may not have given us a blockbuster drug, but it has shown that a combination of lifestyle changes and treatment may be the key to preventing and slowing the disease.
- Bill Gates Is Reupping His Commitment To Alzheimer’s Research And Detectionon July 30, 2022 at 4:00 am
The Alzheimer’s Drug Discovery Foundation, which got a big boost in 2018 from Gates, Jeff Bezos and others, just raised millions more from its billionaire donors and landed four new funders to advance ...
- I Just Received An Alzheimer’s Diagnosis What Do I Do?on July 25, 2022 at 12:20 pm
When you or a loved one receives a diagnosis of Alzheimer's disease or dementia, it can be life shattering, but you need to take action on a wide range of legal, financial, insurance, lifestyle and ...
via Bing News